Vyvanse 59417-0116
Generic: Lisdexamfetamine Dimesylate
Product NDC
59417-0116- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Tablet, Chewable
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 28, 2017
- Listing Expires
- December 31, 2027
- Application
- NDA208510
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 20 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 TABLET, CHEWABLE in 1 BOTTLE (59417-116-01)